Search filters

List of works by Andrew Kuykendall

AML-488 Impact of Somatic Mutations on Treatment Response and Outcomes in Patients With Core Binding Factor Acute Myeloid Leukemia

scientific article published in 2022

Between a rux and a hard place: evaluating salvage treatment and outcomes in myelofibrosis after ruxolitinib discontinuation

scientific article published on 30 November 2017

Driver mutation-specific clinical and genomic correlates differ between primary and secondary myelofibrosis

scientific article published on 10 September 2019

Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis

scientific article published on 14 August 2020

Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype

scientific article published on 18 August 2020

Genetically inspired prognostic scoring system (GIPSS) outperforms dynamic international prognostic scoring system (DIPSS) in myelofibrosis patients

scientific article published on 25 November 2018

Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis

scientific article published on 06 January 2019

Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations

scientific article published in 2022

Monocyte subset analysis accurately distinguishes CMML from MDS and is associated with a favorable MDS prognosis

scientific article published on 3 February 2017

Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 September 2020

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis

scientific article published on 27 February 2020

Poster: AML-488 Impact of Somatic Mutations on Treatment Response and Outcomes in Patients With Core Binding Factor Acute Myeloid Leukemia

scientific article published in 2022

Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis

scientific article published on 16 July 2020

Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera

scientific article published on 22 February 2024

Survival following allogeneic transplant in patients with myelofibrosis

scientific article published on 01 May 2020

The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib Approval.

scientific article published on 5 August 2017

Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO

scientific article published on 01 December 2019

What's in a Number? Examining the Prognostic and Predictive Importance of Platelet Count in Patients With Essential Thrombocythemia

scientific article published on 01 September 2020